SBI Securities’s Immunic IMUX Stock Holding History

SBI Securities’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.73K	Sell	373 -4	-1%	-$49	﹤0.01%	2112
2026 Q1	$4.18K	Buy	377 +16	+4%	+$143	﹤0.01%	2110
2025 Q4	$1.92K	Buy	361 +1	+0.3%	+$7	﹤0.01%	2394
2025 Q3	$3.17K	Sell	360 -1	-0.3%	-$9	﹤0.01%	2240
2025 Q2	$2.51K	Buy	361 +2	+0.6%	+$18	﹤0.01%	2291
2025 Q1	$3.92K	Buy	359 +138	+62%	+$1.49K	﹤0.01%	1997
2024 Q4	$2.21K	Buy	+221	New	+$2.79K	﹤0.01%	2271

Other funds holding IMUX

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

SBI Securities's IMUX Position: Q2 2026 in Review

SBI Securities reduced its Immunic (IMUX) stake by 1.1% in Q2 2026, selling an estimated $49 and leaving 373 shares worth $5.73K. The position accounts for ﹤0.01% of the portfolio, ranked #2112.

SBI Securities first reported a position in IMUX in Q4 2024 and has held it in 7 quarters since. 3 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

SBI Securities held 373 shares of Immunic worth $5.73K as of Q2 2026.
SBI Securities sold 4 Immunic shares in Q2 2026, an estimated $49.
Immunic made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2112 holding.
SBI Securities first reported a position in Immunic in Q4 2024 and has held it in 7 quarters since.
3 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.